Hubbry Logo
Septic arthritisSeptic arthritisMain
Open search
Septic arthritis
Community hub
Septic arthritis
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Septic arthritis
Septic arthritis
Septic arthritis
View on Wikipedia
from Wikipedia

Septic arthritis
Other namesInfectious arthritis, joint infection
Septic arthritis as seen during arthroscopy[1] The arrow points to debris in the joint space.
SpecialtyOrthopedic surgery
SymptomsRed, hot, painful single joint[2]
Usual onsetRapid[2]
CausesBacteria, viruses, fungi, parasites[3]
Risk factorsArtificial joint, prior arthritis, diabetes, poor immune function[2]
Diagnostic methodJoint aspiration with culture[2]
Differential diagnosisRheumatoid arthritis, reactive arthritis, osteoarthritis, gout[2][3]
TreatmentAntibiotics, surgery[2]
MedicationVancomycin, ceftriaxone, ceftazidime[2]
Prognosis15% risk of death (treatment), 66% risk of death (without treatment)[2]
Frequency5 per 100,000 per year[3]

Acute septic arthritis, infectious arthritis, suppurative arthritis, pyogenic arthritis,[4] osteomyelitis, or joint infection is the invasion of a joint by an infectious agent resulting in joint inflammation. Generally speaking, symptoms typically include redness, heat and pain in a single joint associated with a decreased ability to move the joint. Onset is usually rapid. Other symptoms may include fever, weakness and headache. Occasionally, more than one joint may be involved, especially in neonates, younger children and immunocompromised individuals.[2][3][5] In neonates, infants during the first year of life, and toddlers, the signs and symptoms of septic arthritis can be deceptive and mimic other infectious and non-infectious disorders.[5]

In children, septic arthritis is usually caused by non-specific bacterial infection and commonly hematogenous, i.e., spread through the bloodstream.[6][7] Septic arthritis and/or acute hematogenous osteomyelitis usually occurs in children with no co-occurring health problems. Other routes of infection include direct trauma and spread from a nearby abscess. Other less common cause include specific bacteria as mycobacterium tuberculosis, viruses, fungi and parasites.[3] In children, however, there are certain groups that are specifically vulnerable to such infections, namely preterm infants, neonates in general, children and adolescents with hematologic disorders, renal osteodystrophy, and immune-compromised status. In adults, vulnerable groups include those with an artificial joint, prior arthritis, diabetes and poor immune function.[2] Diagnosis is generally based on accurate correlation between history-taking and clinical examination findings, and basic laboratory and imaging findings like joint ultrasound.[5]

In children, septic arthritis can have serious consequences if not treated appropriately and timely. Initial treatment typically includes antibiotics such as vancomycin, ceftriaxone or ceftazidime.[2] Surgery in the form of joint drainage is the gold standard management in large joints like the hip and shoulder.[2][5][8] Without early treatment, long-term joint problems may occur, such as irreversible joint destruction and dislocation.[2]

Signs and symptoms

[edit]

Children

[edit]

In children septic arthritis usually affects the larger joints like the hips, knees and shoulders. The early signs and symptoms of septic arthritis in children and adolescents can be confused with limb injury.[5] Among the signs and symptoms of septic arthritis are: acutely swollen, red, painful joint with fever.[9] Kocher criteria have been suggested to predict the diagnosis of septic arthritis in children.[10]

Importantly, observation of active limb motion or kicking in the lower limb can provide valuable clues to septic arthritis of hip or knee. In neonates/new born and infants the hip joint is characteristically held in abduction flexion and external rotation. This position helps the infant accommodate maximum amount of septic joint fluid with the least tension possible. The tendency to have multiple joint involvements in septic arthritis of neonates and young children should be closely considered.[5]

Adults

[edit]

In adults, septic arthritis most commonly causes pain, swelling and warmth at the affected joint.[2][11] Therefore, those affected by septic arthritis will often refuse to use the extremity and prefer to hold the joint rigidly. Fever is also a symptom; however, it is less likely in older people.[12] In adults the most common joint affected is the knee.[12] Hip, shoulder, wrist and elbow joints are less commonly affected.[13] Spine, sternoclavicular and sacroiliac joints can also be involved. The most common cause of arthritis in these joints is intravenous drug use.[11] Usually, only one joint is affected. More than one joint can be involved if bacteria are spread through the bloodstream.[11]

Prosthetic joint

[edit]
Main article: Prosthetic joint infection

For those with artificial joint implants, there is a chance of 0.86 to 1.1% of getting infected in a knee joint and 0.3 to 1.7% of getting infected in a hip joint.

There are three phases of artificial joint infection: early, delayed and late.[2]

  • Early – infection occurs in less than 3 months. Usual signs and symptoms are fever and joint pain, with redness and warmth over the joint operation site. The mode of infection is during the joint implant surgery. The usual bacteria involved are Staphylococcus aureus and gram negative bacilli.[2]
  • Delayed – infection occurs between 3 and 24 months. There would be persistent joint pain, due to loosening of the implant. The mode of infection is during the implant surgery. Common bacteria are coagulase-negative Staphylococcus and Cutibacterium acnes.[2]
  • Late – more than 24 months. It is usually presented with a sudden onset of joint pain and fever. The mode of infection is through the bloodstream. The bacteria involved are the same as those in septic arthritis of a normal joint.[2]

Cause

[edit]

Septic arthritis is most commonly caused by a bacterial infection.[14] Bacteria can enter the joint by:

Microorganisms in the blood may come from infections elsewhere in the body such as wound infections, urinary tract infections, meningitis or endocarditis.[13] Sometimes, the infection comes from an unknown location. Joints with preexisting arthritis, such as rheumatoid arthritis, are especially prone to bacterial arthritis spread through the blood.[13] In addition, some treatments for rheumatoid arthritis can also increase a person's risk by causing an immunocompromised state.[2] Intravenous drug use can cause endocarditis that spreads bacteria in the bloodstream and subsequently causes septic arthritis.[2] Bacteria can enter the joint directly from prior surgery, intraarticular injection, trauma or joint prosthesis.[11][14][15]

Risk factors

[edit]

In children, although septic arthritis occurs in healthy children and adolescents with no co-occurring health issues, there are certain risk factors that may increase the likelihood of acquiring septic arthritis. For example, children with renal osteodystrophy or renal bone disease, certain hematological disorders and diseases causing immune suppression are risk factors for childhood septic arthritis.[5]

The rate of septic arthritis varies from 4 to 29 cases per 100,000 person-years, depending on the underlying medical condition and the joint characteristics. For those with a septic joint, 85% of the cases have an underlying medical condition while 59% of them had a previous joint disorder.[2] Having more than one risk factor greatly increases risk of septic arthritis.[13]

Organisms

[edit]

Most cases of septic arthritis involve only one organism; however, polymicrobial infections can occur, especially after large open injuries to the joint.[15] Septic arthritis is usually caused by bacteria, but may be caused by viral,[16] mycobacterial, and fungal pathogens as well. It can be broadly classified into three groups: non-gonococcal arthritis, gonococcal arthritis, and others.[2]

  • Non-gonococcal arthritis – These bacteria account for over 80% of septic arthritis cases and are usually staphylococci or streptococci.[2] Such infections most commonly come from drug abuse, cellulitis, abscesses, endocarditis, and chronic osteomyelitis.[2] Methicillin-resistant Staphylococcus aureus (MRSA) may affect 5 to 25% of the cases while gram negative bacilli affects 14 to 19% of the septic arthritis cases. Gram negative infections are usually acquired through urinary tract infections, drug abuse, and skin infections. Older people who are immunocompromised are also prone to get gram negative infections. Common gram negative organisms are: Pseudomonas aeruginosa and Escherichia coli.[2] Both gram positive and gram negative infections are commonly spread through the blood from an infective source; but can be introduced directly into the joint or from surrounding tissue.[11] It often affects older people, and often happens suddenly, involving only one joint. Joint aspiration cultures are positive in 90% of cases, while only 50% of blood cultures yield any organisms.[2]
  • Gonococcal arthritis – Neisseria gonorrhoeae is a common cause of septic arthritis in people who are sexually active and under 40 years old.[2][11] The bacteria is spread through the blood to the joint following sexual transmission. Other symptoms of disseminated gonococcal infection can include migration of joint pain, tenosynovitis and dermatitis.[2][15] Synovial fluid cultures are positive in 25 to 70% of the cases while blood cultures are seldom positive.[2] Apart from blood and joint cultures, swabs from urethra, rectum, pharynx, and cervix should also be taken. Polymerase chain reaction (PCR) is another useful way of identifying gonococcal infections if diagnosis is difficult and clinical presentation is similar to reactive arthritis.[2]
  • Others – Fungal and mycobacterial infections are rare causes of septic arthritis and usually have a slow onset of joint symptoms. Mycobacterial joint infection most commonly affects hip and knee joints, caused by reactivation of past mycobacterial infections, with or without signs and symptoms of tuberculosis in lungs. Synovial fluid cultures will be positive in 80% of the cases. However, acid fast smears are not useful. Histology is not specific to myocobacterial infection as there are other granulomatous diseases that can show similar histology.[2] Borrelia burgdorferi, a bacterium that causes lyme disease, can affect multiple large joints such as the knee. Confirmation of Lyme disease is done through enzyme-linked immunosorbent assay (ELISA) followed by confirmation using Western Blot test. It cannot be cultured from synovial fluid. However, PCR testing yields 85% positive result from synovial fluid.[2] Viruses such as rubella, parvovirus B19, chikungunya, and HIV infection can also cause septic arthritis.[11]
  • Prosthetic joint infection – Artificial joint infection are usually caused by coagulase negative Staphylococci, Staphylococcus aureus, and gram negative bacilli. Concurrent infections by multiple organisms is also reported in 20% of the cases. The risk factors of prosthetic joint infections are: previous fracture, seropositive rheumatoid arthritis, obesity, revision arthroplasty, and surgical site infections.[2]

List of organisms

[edit]

Diagnosis

[edit]
Synovial fluid examination[21][22]
Type WBC (per mm3) % neutrophils Viscosity Appearance
Normal <200 0 High Transparent
Osteoarthritis <5000 <25 High Clear yellow
Trauma <10,000 <50 Variable Bloody
Inflammatory 2,000–50,000 50–80 Low Cloudy yellow
Septic arthritis >50,000 >75 Low Cloudy yellow
Gonorrhea ~10,000 60 Low Cloudy yellow
Tuberculosis ~20,000 70 Low Cloudy yellow
Inflammatory: Arthritis, gout, rheumatoid arthritis, rheumatic fever

Septic arthritis should be considered whenever a person has rapid onset pain in a swollen joint, regardless of fever. One or multiple joints can be affected at the same time.[2][11][12]

Laboratory studies such as blood cultures, white blood cell count with differential, ESR, and CRP should also be included. However, white cell count, ESR, and CRP are nonspecific and could be elevated due to infection elsewhere in the body. Serologic studies should be done if lyme disease is suspected.[11][15] Blood cultures can be positive in 25 to 50% of those with septic arthritis due to spread of infection from the blood.[2] CRP more than 20 mg/L and ESR greater than 20 mm/hour together with typical signs and symptoms of septic arthritis should prompt arthrocentesis from the affected joint for synovial fluid examination.[9]

The synovial fluid should be collected before the administration of antibiotics and should be sent for gram stain, culture, leukocyte count with differential, and crystal studies.[11][13] This can include NAAT testing for N. gonorrhoeae if suspected in a sexually active person.[15]

In children, the Kocher criteria is used for diagnosis of septic arthritis.[23]

Differential diagnosis

[edit]

The differential diagnosis of septic arthritis is broad and challenging. First, it has to be differentiated from acute hematogenous osteomyelitis. This is because the treatment lines of both conditions are not identical. Noteworthy, septic arthritis and acute hematogenous osteomyelitis can co-occur. Especially in the hip and shoulder joints their co-occurrence is likely and represents a diagnostic challenge. Therefore, physicians should have a high suspicion index in that regard. This is because in both the hip and shoulder joints the metaphysis is intra-articular which in turn facilitates the spread of hematogenous osteomyelitis into the joint cavity. Conversely, joint sepsis may spread to the metaphysis and induce osteomyelitis.[5] Acute exacerbation of juvenile idiopathic arthritis and transient synovitis of the hip both of which are non-septic conditions may mimic septic arthritis. More serious and life-threatening disorders as bone malignancies e.g. Ewing sarcoma and osteosarcoma may mimic septic arthritis associated with concurrent acute hematogenous osteomyelitis. In this regard, Magnetic resonance imaging may play an important role in the differential diagnosis.[5][24]

Joint aspiration

[edit]

In children, joint synovial fluid aspiration techniques aim at isolating the infectious organism by culture and sensitivity analysis. Cytological analysis of the joint aspirate can point to septic arthritis. However, a negative culture and sensitivity test does not rule out the presence of septic arthritis. Various clinical scenarios and technique-related factors may impact the validity of results of the culture and sensitivity. Additionally, results of cytological analysis, though important, should not be interpreted in isolation of the clinical settings.[5][25]

Synovial fluid from a knee with septic arthritis

In the joint fluid, the typical white blood cell count in septic arthritis is over 50,000–100,000 cells per 10−6/l (50,000–100,000 cell/mm3);[26] where more than 90% are neutrophils is suggestive of septic arthritis.[2] For those with prosthetic joints, white cell count more than 1,100 per mm3 with neutrophil count greater than 64% is suggestive of septic arthritis.[2] However, septic synovial fluid can have white blood cell counts as low as a few thousand in the early stages. Therefore, differentiation of septic arthritis from other causes is not always possible based on cell counts alone.[13][26] Synovial fluid PCR analysis is useful in finding less common organisms such as Borrelia species. However, measuring protein and glucose levels in joint fluid is not useful for diagnosis.[2]

The Gram stain can rule in the diagnosis of septic arthritis, however, cannot exclude it.[13]

Synovial fluid cultures are positive in over 90% of nongonoccocal arthritis; however, it is possible for the culture to be negative if the person received antibiotics prior to the joint aspiration.[11][13] Cultures are usually negative in gonoccocal arthritis or if fastidious organisms are involved.[11][13]

If the culture is negative or if a gonococcal cause is suspected, NAAT testing of the synovial fluid should be done.[11]

Positive crystal studies do not rule out septic arthritis. Crystal-induced arthritis such as gout can occur at the same time as septic arthritis.[2]

A lactate level in the synovial fluid of greater than 10 mmol/L makes the diagnosis very likely.[27]

Blood tests

[edit]

Laboratory testing includes white blood cell count, ESR and CRP. These values are usually elevated in those with septic arthritis; however, these can be elevated by other infections or inflammatory conditions and are, therefore, nonspecific.[2][11] Procalcitonin may be more useful than CRP.[28]

Blood cultures can be positive in up to half of people with septic arthritis.[2][13]

Imaging

[edit]

Imaging such as x-ray, CT, MRI or ultrasound are nonspecific. They can help determine areas of inflammation but cannot confirm septic arthritis.[14]

When septic arthritis is suspected, x-rays should generally be taken.[13] This is used to assess any problems in the surrounding structures[13] such as bone fractures, chondrocalcinosis, and inflammatory arthritis which may predispose to septic arthritis.[2] While x-rays may not be helpful early in the diagnosis/treatment, they may show subtle increase in joint space and tissue swelling.[11] Later findings include joint space narrowing due to destruction of the joint.[14]

Ultrasound is effective at detecting joint effusions.[14]

CT and MRI are not required for diagnosis; but if the diagnosis is unclear or the joints are hard to examine (ie.sacroiliac or hip joints); they can help to assess for inflammation/infection in or around the joint (i.e. Osteomyelitis),[13][14] bone erosions, and bone marrow oedema.[2] Both CT and MRI scans are helpful in guiding arthrocentesis of the joints.[2]

Differential diagnosis

[edit]

Treatment

[edit]

Treatment is usually with intravenous antibiotics, analgesia and washout and/or aspiration of the joint.[11][13] Draining the pus from the joint is important and can be done either by needle (arthrocentesis) or opening the joint surgically (arthrotomy).[2]

Empiric antibiotics for suspected bacteria should be started. This should be based on Gram stain of the synovial fluid as well as other clinical findings.[2][11] General guidelines are as follows:

Once cultures are available, antibiotics can be changed to target the specific organism.[11][13] After a good response to intravenous antibiotics, people can be switched to oral antibiotics. The duration of oral antibiotics varies, but is generally for 1–4 weeks depending on the offending organism.[2][11][13] Repeated daily joint aspiration is useful in the treatment of septic arthritis. Every aspirate should be sent for culture, gram stain, white cell count to monitor the progress of the disease. Both open surgery and arthroscopy are helpful in the drainage of the infected joint. During surgery, lysis of the adhesions, drainage of pus, and debridement of the necrotic tissues are done.[2] Close follow up with physical exam & labs must be done to make sure the person is no longer feverish, pain has resolved, has improved range of motion, and lab values are normalized.[2][13]

In infection of a prosthetic joint, a biofilm is often created on the surface of the prosthesis which is resistant to antibiotics.[29] Surgical debridement is usually indicated in these cases.[2][30] A replacement prosthesis is usually not inserted at the time of removal to allow antibiotics to clear infection of the region.[14][30] People that cannot have surgery may try long-term antibiotic therapy in order to suppress the infection.[14] The use of prophylactic antibiotics before dental, genitourinary, gastrointestinal procedures to prevent infection of the implant is controversial.[2]

Low-quality evidence suggests that the use of corticosteroids may reduce pain and the number of days of antibiotic treatment in children.[31]

Outcomes

[edit]

Risk of permanent impairment of the joint varies greatly.[13] This usually depends on how quickly treatment is started after symptoms occur as longer lasting infections cause more destruction to the joint. The involved organism, age, preexisting arthritis, and other comorbidities can also increase this risk.[14] Gonococcal arthritis generally does not cause long term impairment.[11][13][14] For those with Staphylococcus aureus septic arthritis, 46 to 50% of the joint function returns after completing antibiotic treatment. In pneumococcal septic arthritis, 95% of the joint function will return if the person survives. One-third of people are at risk of functional impairment (due to amputation, arthrodesis, prosthetic surgery, and deteriorating joint function) if they have an underlying joint disease or a synthetic joint implant.[2] Mortality rates generally range from 10 to 20%.[14] These rates increase depending on the offending organism, advanced age, and comorbidities such as rheumatoid arthritis.[13][14][15]

Epidemiology

[edit]

In children and adolescence septic arthritis and acute hematogenous osteomyelitis occurs in about 1.34 to 82 per 100,000 per annual hospitalization rates.[32][33][34][35] In adults septic arthritis occurs in about 5 people per 100,000 each year.[3] It occurs more commonly in older people.[3] With treatment, about 15% of people die, while without treatment 66% die.[2]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Septic arthritis

View on Grokipedia
from Grokipedia
Septic arthritis, also known as infectious arthritis, is an acute or subacute of a caused by pathogenic microorganisms such as , fungi, mycobacteria, or viruses, leading to rapid and potential joint destruction if untreated. It most commonly affects a single joint (monoarticular), with the being the most frequent site in adults and the in children, and arises primarily through hematogenous spread from a distant site, direct via trauma or , or extension from adjacent . The most prevalent causative agent is Staphylococcus aureus, accounting for approximately 40-50% of cases in both children and adults, followed by streptococcal species and, in specific populations, pathogens like in sexually active adolescents or in young children under 3 years. Fungal or mycobacterial infections are less common but occur more frequently in immunocompromised individuals, while viral etiologies are rare. Risk factors include extremes of age (neonates, infants, and elderly over 80), prosthetic joints, chronic conditions such as , , or , intravenous drug use, and immunosuppression from medications or . The incidence is estimated at 2-6 cases per 100,000 people annually, with higher rates in males during childhood peaks (ages 2-3) and in those with joint prostheses. Clinically, septic arthritis presents with sudden onset of severe joint pain, swelling, , warmth, and restricted , often accompanied by systemic signs like fever (in 40-60% of cases) and chills, though these may be absent in up to 50% of patients, particularly the elderly or immunocompromised. In infants, symptoms may manifest as , refusal to bear weight, or pseudoparalysis of the affected limb. Pathophysiologically, bacterial invasion of the triggers an intense inflammatory response with release and enzymatic degradation, potentially eroding and bone within days. Diagnosis relies on for analysis, revealing elevated white blood cell counts (>50,000 cells/μL with >90% neutrophils), positive or culture in 50-70% of cases, and blood cultures identifying the in about 40% of instances. such as or MRI aids in detecting effusions but is not definitive, while plain radiographs may show only swelling initially. Treatment involves urgent joint drainage via needle aspiration, , or open arthrotomy, combined with empiric intravenous antibiotics (e.g., plus ) tailored by culture results, typically administered for 2-6 weeks depending on the and host factors. Without prompt intervention, septic arthritis carries a of 7-15% and functional morbidity in up to 33% of survivors, including , stiffness, and due to irreversible joint damage; outcomes improve significantly with early and , though prosthetic joint infections may necessitate implant removal.

Signs and symptoms

In children

Septic arthritis in children often affects the hip joint most frequently, which can lead to to the , followed by the and , with the ankle and involved less commonly. Key symptoms include pseudoparalysis, characterized by refusal to move the affected limb, along with and , particularly during movements such as diaper changes. In older children, a or refusal to bear weight is typical, while toddlers may revert to crawling to avoid discomfort. Physical signs encompass high-grade fever in many cases, joint swelling that may be subtle in deeper structures like the , localized warmth, and tenderness upon . Systemic toxicity tends to be more pronounced in children compared to adults, manifesting as an ill appearance with and fussiness. For hip involvement specifically, the limb is often held in flexion, abduction, and external rotation to minimize pain, and children are typically unable to bear weight on the affected side. Age-specific variations influence the clinical picture significantly. Neonates commonly present with poor feeding, lethargy, and irritability rather than localized , alongside a higher likelihood of multifocal involvement. In infants with septic hip arthritis, physical findings may include leg shortening or asymmetry due to and muscle spasm. School-age children are more apt to report directly localized to the affected , facilitating earlier recognition. If septic arthritis remains unrecognized in children, it can lead to rapid destruction, attributable to the thinner in pediatric joints, potentially resulting in , growth disturbances, or leg length discrepancies.

In adults

Septic arthritis in adults most commonly manifests as an acute monoarticular , with the knee joint affected in 50-60% of cases, followed by the , , and . The hallmark symptoms include a sudden onset of intense joint pain that intensifies with any movement, often accompanied by fever, chills, and , along with markedly limited in the affected . On , characteristic signs consist of , overlying , warmth, and exquisite tenderness, with patients typically exhibiting guarding or voluntary splinting of the involved limb to protect it from motion. In elderly adults, the clinical picture may be more subtle, featuring a less pronounced fever and a more gradual onset of symptoms compared to younger patients. In contrast, young adults aged 15 to 30 years often experience septic arthritis as part of disseminated gonococcal , presenting initially with migratory that later localizes to a single joint. Associated features frequently include a recent history of trauma, , or intra-articular injection, while rigors are reported in approximately 20% of cases alongside other systemic signs.

In prosthetic joints

Septic arthritis in prosthetic joints, also known as periprosthetic infection (PJI), is classified by timing of onset relative to the index , which influences clinical presentation and . Early-onset PJI occurs within 3 months postoperatively and is typically due to acute hematogenous seeding or perioperative by highly virulent organisms. Delayed-onset infections arise between 3 and 12 months, often from less virulent pathogens introduced during . Late-onset PJI, beyond 12 months, usually results from chronic low-grade hematogenous spread, leading to indolent infections characterized by formation on the , which promotes persistent bacterial and resistance. Patients with PJI commonly experience persistent pain at rest or during the night, instability, and prosthetic loosening, which may mimic aseptic . Unlike acute native septic arthritis, high fever and systemic inflammatory response are often absent, particularly in delayed or late cases, making challenging. Reduced function, such as limping or inability to ambulate in lower extremity involvement, is frequent and progressive. Clinical signs include periprosthetic swelling, erythema, warmth, and wound drainage, with sinus tract formation being a pathognomonic feature in chronic presentations, indicating communication between the joint and skin. These signs reflect ongoing inflammation and potential biofilm-mediated persistence. Diagnostic clues encompass a history of recent bacteremia, such as following dental procedures, which can seed the prosthesis hematogenously in late infections. Biofilm formation contributes to diagnostic difficulty by allowing low-grade, smoldering infection without overt systemic signs. PJI accounts for approximately 1% to 2% of all primary hip and knee arthroplasties, with higher cumulative incidence over time (up to 1.4% for hips and 2.0% for knees at 15 years) and predominance in these joints due to their frequency of replacement.

Causes and risk factors

Risk factors

Septic arthritis is associated with a range of risk factors that increase susceptibility to , including both modifiable and non-modifiable elements. Immunocompromising conditions significantly elevate the risk, with (RA) being a prominent example; patients with RA have a 10- to 15-fold higher incidence of septic arthritis compared to the general population, and RA accounts for approximately 20-30% of all cases. Other immunocompromising factors include diabetes mellitus, which impairs immune response and wound healing; human immunodeficiency virus () , which weakens overall immunity; malignancy, particularly hematologic types like ; and chronic steroid use, which suppresses inflammatory defenses. Joint-related risks often stem from breaches in the or pre-existing damage. Prior joint surgery, including procedures like , introduces potential entry points for pathogens. Prosthetic joints carry a postoperative risk of 0.3-1%, with early infections occurring within months due to surgical and late ones from hematogenous spread. Intra-articular injections, such as corticosteroids, and recent trauma or fractures further compromise joint integrity, facilitating bacterial invasion. Systemic factors that promote hematogenous dissemination of pathogens include intravenous drug use, which heightens the risk through contaminated needles and direct bloodstream access, often leading to infections in atypical joints like the sacroiliac. Indwelling catheters, such as central venous lines, serve as reservoirs for bacteremia, while chronic skin infections or ulcers provide ongoing sources of microbial entry into the circulation. Demographic risks highlight vulnerable populations, including extremes of age—infants under 3 years and adults over 80—who exhibit higher incidence rates due to immature or declining immune function. contributes through liver dysfunction and immunosuppression, while predisposes via vaso-occlusive crises that damage joints and impair splenic clearance of bacteria.

Pathogenic organisms

Septic arthritis is primarily caused by bacterial pathogens, with accounting for the majority of cases. Among these, is the most common etiologic agent, responsible for approximately 40-60% of infections across various populations, including both methicillin-sensitive strains (MSSA) and methicillin-resistant strains (MRSA), the latter being particularly prevalent in regions with high resistance rates. species rank second, comprising 20-30% of cases, with notable examples including (group A Streptococcus) and , the latter more frequent in asplenic patients due to impaired opsonization. is a common cause in young children under 4 years, responsible for 30-50% of septic arthritis cases in this age group. Gram-negative bacteria cause 10-20% of septic arthritis cases overall, though this proportion rises to 23-30% in elderly patients or those with comorbidities such as urinary tract infections. Common pathogens include and , the latter often associated with intravenous drug use (IVDU) or advanced age. Neisseria gonorrhoeae is a key cause in sexually active young adults, accounting for 20-30% of septic arthritis cases in this demographic through disseminated gonococcal infection originating from mucosal sites. Less common pathogens include anaerobes, which account for about 5% of cases and are typically linked to or compromised tissue perfusion. Fungal infections, such as those caused by Candida species, are rare and predominantly occur in immunocompromised individuals. Mycobacteria, including , are associated with chronic, indolent presentations. Other organisms include , which was prevalent in children prior to widespread vaccination but is now rare, and species, particularly in patients with due to functional and reticuloendothelial dysfunction. Virulence factors play a critical role in the pathogenicity of these organisms. For S. aureus, key mechanisms involve the production of toxins such as alpha-toxin and Panton-Valentine leukocidin, which lyse host cells, alongside adhesins that promote binding to matrix proteins and formation that enhances intra-articular persistence and resistance. N. gonorrhoeae facilitates invasion through hematogenous dissemination, aided by its ability to evade complement-mediated killing via sialylation of lipooligosaccharides. These factors collectively enable microbial survival, replication, and induction of severe inflammatory responses within the synovial space.

Pathophysiology

Mechanisms of joint infection

Septic arthritis primarily arises through three main routes of entry into the space: hematogenous spread, direct , and contiguous extension from adjacent infections. Hematogenous spread is the most common mechanism, in which bacteria from distant sites such as skin infections, urinary tract infections, or respiratory infections enter the bloodstream during episodes of bacteremia and seed the synovial vasculature. This route is facilitated by the synovial membrane's rich vascular supply and absence of a limiting , which allows circulating s to easily adhere to and penetrate the synovium. Common organisms involved include , which binds to synovial components like and via microbial surface components recognizing adhesive matrix molecules (MSCRAMMs). Direct inoculation occurs when pathogens are introduced directly into the joint through trauma, surgical procedures, joint aspirations, or penetrating injuries such as bites. This mechanism often leads to polymicrobial s, particularly in cases involving open wounds or iatrogenic interventions. Contiguous spread involves extension of from adjacent structures, such as in nearby bone or soft tissue abscesses, with the and joints being particularly susceptible due to their anatomical proximity to potential sites. The synovium's inherent vulnerability exacerbates these entry mechanisms; its highly vascular nature without a protective basement plate permits rapid bacterial adhesion and invasion, while in prosthetic joints, pathogens like coagulase-negative staphylococci promote formation on surfaces, shielding them from host defenses. Following initial seeding, infection progresses swiftly: bacteria proliferate in the nutrient-rich , leading to congestion and early inflammatory changes within hours to days, potentially causing erosion if not addressed promptly.

Inflammatory processes

Upon bacterial invasion of the joint space, bacterial antigens initiate an acute inflammatory response by stimulating the release of pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) from synovial cells and macrophages. These cytokines promote the rapid influx of neutrophils into the and tissue, leading to the formation of and marked synovial characterized by proliferation of the synovial lining. This early cascade amplifies local inflammation, with neutrophils releasing and additional mediators that further exacerbate tissue injury. The inflammatory milieu drives joint damage through the activation of proteolytic enzymes, particularly matrix metalloproteinases (MMPs) produced by synovial fibroblasts and activated neutrophils. These enzymes degrade components, resulting in progressive erosion of articular cartilage and subchondral bone. Concurrently, the accumulation of inflammatory increases intra-articular pressure, which compromises vascular supply to the synovium and cartilage, inducing ischemia and further of joint tissues. A critical early consequence is the rapid loss of proteoglycans from the matrix, which impairs the biomechanical integrity of and initiates irreversible chondrolysis. formation within the cavity intensifies this process by mechanically disrupting surfaces and providing a nidus for continued enzymatic degradation. If the infection persists untreated, the inflammatory response transitions to a chronic phase, where ongoing signaling and immune cell infiltration promote synovial and eventual , severely limiting mobility. Host factors, such as impaired immune function in conditions like or , hinder effective bacterial clearance by neutrophils and macrophages, thereby prolonging the inflammatory cascade and accelerating tissue destruction.

Diagnosis

Synovial fluid analysis

analysis is a critical diagnostic procedure for confirming septic arthritis, involving the aspiration of joint fluid through performed urgently under sterile conditions to minimize risk. The procedure typically uses an 18- to 20-gauge needle and , with guidance recommended for deeper or difficult-to-access joints such as the to improve accuracy and safety. Obtained fluid is immediately transported to the for evaluation, including cell count with differential, , , and crystal analysis to differentiate infection from other arthropathies. Key diagnostic findings in synovial fluid from septic arthritis include a white blood cell (WBC) count exceeding 50,000 cells/μL in native joints, often with more than 90% polymorphonuclear leukocytes, indicating an acute bacterial process; lower thresholds (e.g., >3,000 cells/μL with >80% PMNs) apply to prosthetic joint infections. A positive , which identifies bacterial morphology and guides initial selection, has a sensitivity of 50% to 70% but high specificity. Synovial fluid culture remains the gold standard for pathogen identification, with a yield of 70% to 90% in untreated cases, though prior exposure can reduce positivity rates. Additional biochemical tests, such as lactate, glucose, and protein levels, may provide supportive evidence of by reflecting bacterial and but lack standardized cutoffs and are not primary diagnostics. Emerging biomarkers like synovial calprotectin (cutoff ≥50 mg/L) offer high for distinguishing septic from non-septic arthritis. In culture-negative cases, particularly those involving fastidious organisms, (PCR) testing can provide rapid identification of pathogens such as or atypical bacteria. Contraindications to include overlying unstable or severe , as these increase procedural risks. Complications are rare, with iatrogenic occurring in less than 0.1% of cases when sterile technique is followed. Macroscopic examination of the aids initial interpretation; septic arthritis often presents with turbid, purulent of decreased due to high cellularity and enzymatic degradation, contrasting with clearer, more viscous in non-infectious conditions.

Blood tests

Peripheral blood tests play a supportive role in the diagnosis of septic arthritis by indicating and potential bacteremia, though they lack specificity and cannot confirm the alone. These tests are routinely obtained in suspected cases to guide further evaluation, such as analysis. Inflammatory markers, including (ESR) and (CRP), are commonly elevated in septic arthritis. ESR greater than 30 mm/hr is nonspecific but often present, while CRP levels exceeding 100 mg/L rise early in infection and demonstrate high sensitivity, with both markers elevated in approximately 80-90% of cases. Complete blood count typically reveals leukocytosis greater than 11,000/μL with a left shift in 50-70% of patients, reflecting the acute inflammatory response. In subacute presentations, anemia of chronic disease may also be observed. Blood cultures are recommended in all suspected cases due to the potential for hematogenous spread, yielding positive results in 20-50% of patients overall, with higher rates in gonococcal or Staphylococcus aureus infections. Additional tests include levels greater than 0.5 ng/mL, which aid in confirming bacterial with good specificity, and assessments of renal and liver function to evaluate comorbidities that may influence . These blood tests may yield normal results in early disease or immunocompromised patients, underscoring their limitations and the need for joint-specific diagnostics.

Imaging studies

Plain radiography serves as the initial imaging modality for suspected septic arthritis due to its accessibility and low cost. In the early stages, radiographs are often normal or show only nonspecific swelling and , with more advanced findings such as periarticular , marginal erosions, and uniform joint space narrowing appearing after 7-10 days of infection. Ultrasound is a valuable bedside tool for detecting joint effusions, with a sensitivity of approximately 90% for identifying intra-articular fluid collections, making it particularly useful in superficial joints like the knee or shoulder. It can guide diagnostic aspiration and therapeutic drainage in real time, and dynamic imaging may assess prosthetic joint loosening in cases of suspected infection. Beyond visualization, the presence of an effusion on ultrasound often prompts joint aspiration for synovial fluid analysis to confirm the diagnosis. Magnetic resonance imaging (MRI) is considered the gold standard for early detection of septic arthritis, offering a sensitivity of up to 95% for identifying synovial abnormalities and associated complications. Key findings include with synovial thickening and enhancement after administration, T2-weighted hyperintense signals indicating or , and extension to adjacent or formation, which helps delineate the full extent of infection. Computed tomography (CT) is less sensitive for details but excels in evaluating bony involvement in chronic or complicated cases, revealing erosions, sequestra, or gas within the . It is particularly useful for preoperative and guiding surgical interventions, such as drainage in deep joints. Nuclear , including labeled leukocyte scans, is infrequently used but can detect infections in prosthetic joints when other modalities are inconclusive, with high sensitivity for periprosthetic uptake indicating or . Triple-phase bone scans may show increased blood flow and delayed uptake in affected areas, though specificity is limited without leukocyte labeling.

Differential diagnosis

Crystal arthropathies

Crystal arthropathies, such as and pseudogout, are important mimics of septic arthritis due to their acute inflammatory presentations involving monoarticular joint swelling, pain, and warmth. These conditions arise from the deposition of specific crystals in , triggering intense but typically self-limited inflammation, unlike the bacterial-driven destruction in septic arthritis. Gout, the most common crystal arthropathy, results from leading to the formation and deposition of monosodium urate (MSU) crystals in joints and soft tissues. Acute attacks often manifest as podagra, an of the first metatarsophalangeal joint, while chronic features tophaceous deposits that can erode bone and cartilage. In analysis, MSU crystals appear as needle-shaped structures exhibiting negative under . Pseudogout, or deposition (CPPD) disease, involves the accumulation of dihydrate (CPPD) crystals, predominantly affecting elderly individuals with a predilection for the and joints. These crystals display positive and a rhomboid morphology on polarized . CPPD is associated with metabolic disorders, including hemochromatosis, which promotes crystal formation through mechanisms. Coexistent septic arthritis and crystal arthropathy occurs in approximately 5% of crystal-induced cases, particularly in immunocompromised patients where bacterial complicates crystal-mediated . Crystal arthropathies are generally monoarticular and self-limiting, with fever being less prominent compared to septic arthritis. Distinguishing these entities relies on examination: septic arthritis typically shows leukocyte counts exceeding 50,000 cells/mm³ with predominant polymorphonuclear cells and positive bacterial cultures, whereas crystal arthropathies demonstrate lower or variable counts and diagnostic crystals identifiable via compensated . is far more prevalent than septic arthritis, with an estimated annual incidence of about 0.2% versus 0.01% for septic cases in the general .

Other arthritides

Other arthritides that mimic septic arthritis include post-infectious, viral, traumatic, and autoimmune conditions, which present with acute , swelling, and but lack bacterial in the joint space. These mimics are distinguished primarily through , analysis showing sterile or non-purulent fluid, and absence of systemic signs like high fever or positive cultures. Prompt differentiation is essential to avoid unnecessary surgical intervention. Reactive arthritis, also known as Reiter's syndrome, is a sterile, inflammatory occurring 1-4 weeks after gastrointestinal (e.g., , , ) or genitourinary (e.g., ) infections. It typically affects lower extremity joints asymmetrically, accompanied by (inflammation at tendon insertions) and extra-articular features like or , with a strong association to positivity in 50-80% of cases. is inflammatory (WBC 5,000-50,000/μL, predominantly neutrophils) but sterile, contrasting with the purulent fluid and bacterial growth in septic arthritis; diagnosis relies on clinical history and exclusion of . Lyme arthritis, the late manifestation of caused by the spirochete transmitted via tick bites in endemic areas, commonly involves the in a mono- or oligoarticular pattern. Patients often have a history of rash or prior flu-like symptoms, with episodic swelling over months to years. shows marked inflammation (WBC >50,000/μL possible, predominantly neutrophils), but cultures are negative; PCR detection of B. burgdorferi DNA confirms diagnosis, and it responds well to oral (100 mg twice daily for 28 days) without drainage in most cases, unlike the acute, destructive course of septic arthritis requiring IV antibiotics and surgery. Viral arthritides, such as those from , , or hepatitis C, cause acute, symmetric often involving small joints of the hands and feet, mimicking septic arthritis through sudden onset and . typically presents with a self-limited course (1-3 weeks), preceded by a of fever and , and associated with a characteristic slapped-cheek in children or lacy reticular in adults; is inflammatory but sterile with low WBC counts (<10,000/μL). -related arthritis occurs in the prodromal phase before jaundice, with polyarticular involvement and urticaria, resolving spontaneously; hepatitis C may cause chronic symmetric arthritis linked to cryoglobulinemia, but both feature negative bacterial cultures and serologic confirmation via viral markers. Traumatic hemarthrosis results from intra-articular bleeding following injury, such as anterior cruciate ligament tears (70% of knee cases) or fractures, leading to rapid joint swelling, pain, and limited motion within hours. It lacks systemic symptoms like fever and is identified by a clear history of trauma; synovial aspirate is bloody (red, pink, or brown, non-clotting due to fibrinolysis) with possible fat globules (lipohemarthrosis) indicating occult fracture, differing from the purulent, high-WBC (>50,000/μL) fluid in septic arthritis. focuses on immobilization and addressing the underlying injury, without antibiotics. Flares of autoimmune diseases like (RA) or systemic (SLE) can simulate septic arthritis with acute mono- or polyarticular swelling, warmth, and pain, particularly in patients with established disease. In RA flares, analysis reveals inflammatory cells (WBC 2,000-50,000/μL, mostly polymorphonuclear) but sterile cultures and lower viscosity compared to septic cases; SLE flares may involve similar fluid findings with additional systemic features like rash or . Differentiation requires correlation with chronicity, seropositivity (e.g., , anti-CCP in RA; ANA in SLE), and response to disease-modifying agents rather than acute antibiotics.

Treatment

Antibiotic therapy

Antibiotic therapy for septic arthritis begins with empiric intravenous (IV) regimens designed to cover the most common pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), streptococci, gram-negative bacilli, and in at-risk populations. For adults, a typical empiric regimen consists of IV (15-20 mg/kg every 8-12 hours, adjusted for renal function) combined with (1-2 g every 24 hours) to provide broad coverage; alternatives include cefepime (2 g every 8 hours) if is suspected in immunocompromised patients. Regimens should be adjusted based on local patterns, with consultation from infectious disease specialists recommended. Once culture and sensitivity results from synovial fluid or blood are available, typically within 48-72 hours, therapy is de-escalated to pathogen-specific agents to optimize efficacy and minimize resistance. For methicillin-sensitive S. aureus (MSSA), nafcillin (1.5-2 g IV every 4 hours) or oxacillin is preferred, with a total duration of 4-6 weeks. For N. gonorrhoeae, ceftriaxone (1 g IV or intramuscularly daily) is used for 7-14 days, often sufficient without prolonged therapy due to the organism's sensitivity. In cases of gram-negative infections, such as those caused by Enterobacteriaceae, third-generation cephalosporins like ceftriaxone or fluoroquinolones (e.g., ciprofloxacin 400 mg IV every 12 hours) are targeted based on susceptibilities, with durations of 3-4 weeks. Initial treatment is administered intravenously for 2-4 weeks to ensure high , followed by oral switch to bioequivalent agents (e.g., for or trimethoprim-sulfamethoxazole for MRSA) for the remainder of the 4-6 week total course in native joint infections, provided clinical improvement and oral tolerance are achieved. Serial monitoring of (CRP) levels, along with (ESR) and white blood cell count, guides response assessment, with CRP expected to decline by at least 50% within 3-5 days of effective therapy. Lack of improvement in pain, fever, or inflammatory markers within 3-5 days prompts reevaluation for abscesses, resistant organisms, or inadequate source control. In special cases, such as prosthetic joint infections, therapy incorporates rifampin (300-450 mg orally every 12 hours) added to pathogen-specific agents like or for penetration, with total durations extended to 6-12 weeks or longer, often requiring suppressive oral indefinitely if hardware retention is pursued. For pediatric patients, mirrors adults but uses weight-based dosing (e.g., 15 mg/kg IV every 6 hours, 50-75 mg/kg IV daily) and should include coverage for in children aged 6-48 months; total durations are 10-14 days for uncomplicated cases with rapid improvement, or 21-28 days for complicated or less susceptible pathogens, tailored to age and organism, with transition to oral recommended after 2-7 days of IV treatment if there is clinical improvement and declining CRP levels.

Surgical interventions

Surgical interventions are essential for managing septic arthritis when conservative measures alone are insufficient, particularly to achieve mechanical clearance of infected material from the space. Indications for surgery include failure of initial to control the infection, presence of large joint effusions that cannot be adequately drained by aspiration, and infections involving prosthetic joints, where formation complicates eradication. In native joints, surgical intervention is considered urgent to prevent irreversible damage and joint destruction, often within 24-48 hours of . Arthroscopic drainage serves as the first-line surgical approach for most native joint infections, involving lavage to remove purulent material and of infected synovium and necrotic tissue. This minimally invasive technique is preferred for accessible joints like the , , and due to reduced postoperative morbidity, shorter stays, and faster recovery compared to open procedures. Studies report success rates of 80-95% in eradicating when combined with systemic antibiotics, with lower reoperation rates than open in uncomplicated cases. Open arthrotomy is indicated for complex cases, such as infections in the or when is technically challenging due to anatomical constraints or extensive purulence. This procedure provides direct visualization and allows for thorough , , and removal of debris, which is particularly beneficial in pediatric patients or those with deep-seated s. While effective in achieving control, it is associated with higher risks of complications and prolonged rehabilitation compared to . In prosthetic joint infections, management strategies are tailored to the infection's acuity and host factors. For early postoperative or acute hematogenous infections (typically within 3-4 weeks of implantation), , s, and implant retention (DAIR) is the preferred approach, involving thorough , exchange of modular components, and retention of the if stable. Success rates with DAIR range from 50-80% in selected patients with good coverage and susceptible pathogens. For chronic infections (>3 months) or failed DAIR, options include resection with spacer placement followed by two-stage reimplantation, which achieves eradication in over 90% of cases but requires extended and rehabilitation. Adjunctive measures during surgery enhance outcomes by supporting local delivery and ongoing drainage. Continuous closed systems, using catheters for saline or -infused lavage, can be employed post-debridement to maintain joint patency and reduce bacterial load over 24-48 hours. Additionally, polymethylmethacrylate (PMMA) s impregnated with (e.g., or gentamicin) provide sustained local release in severe or cases, particularly for prosthetic infections or when systemic are limited by resistance; these are typically removed after 2-6 weeks to avoid complications like migration.

Prognosis

Short-term outcomes

The short-term for septic arthritis is approximately 7% to 15% during hospitalization, primarily attributable to systemic and underlying comorbidities. This rate increases to 20% to 50% in cases involving elderly patients or polyarticular involvement, where advanced age and multi-joint dissemination exacerbate septic complications. With early intervention, including prompt joint drainage and targeted antibiotics initiated within 24 hours of symptom onset, cure rates for septic arthritis reach 90% to 95% in native joints, reflecting successful eradication of without immediate recurrence. Treatment failure occurs in 10% to 20% of cases, often necessitating repeat surgical due to persistent or inadequate initial response. The typical hospital course for septic arthritis lasts 7 to 14 days, with most patients experiencing substantial pain relief within 3 to 7 days following initiation of antibiotics and drainage. (CRP) levels, a key marker of inflammatory response, generally normalize within 1 to 2 weeks in responsive cases, guiding the transition from intravenous to oral therapy. Outcomes are more favorable in native joints compared to prosthetic ones, with retention rates of approximately 90% versus 50% following and antibiotics, as prosthetic infections often require implant removal for control. In pediatric patients, resolution of acute symptoms tends to occur more rapidly than in adults due to robust immune responses and less burden, though involvement near growth plates carries a heightened risk of physeal damage.

Long-term complications

Septic arthritis can lead to significant destruction, primarily through loss that predisposes affected individuals to secondary . Studies indicate that up to 50% of adults experience substantial dysfunction, with degradation occurring rapidly and contributing to degenerative changes in 30-50% of cases, particularly in the and . , or joint fusion, can develop in untreated or delayed cases, often resulting in fibrous or bony immobilization that severely limits mobility. Functional deficits persist in 20-40% of patients post-resolution, manifesting as reduced , , and impaired daily activities. These sequelae frequently necessitate total in 10-20% of individuals within 10-15 years, with survival rates dropping to about 65% at 10 years due to progressive degeneration. In cases involving prosthetic joints, the risk of reinfection rises to 5-10%, compounded by chronic sinus tracts that promote persistent bacterial colonization and require repeated interventions. Pediatric patients face unique growth-related complications, including leg length discrepancy from physeal damage and of the , which can alter skeletal development and necessitate corrective surgeries. Systemic effects, such as , are rare but occur in recurrent or chronic cases, driven by prolonged inflammation and infection.

Epidemiology

Incidence and prevalence

Septic arthritis has an estimated global incidence of 2 to 10 cases per 100,000 persons annually, with rates varying based on population characteristics and healthcare access. , approximately 20,000 cases occur each year, corresponding to an incidence of about 7.8 cases per 100,000 person-years, and the is the most commonly affected . Among hospitalized patients, particularly those with underlying conditions, the incidence rises to 20 to 30 cases per 100,000. For native joints, the incidence is typically 4 to 5 cases per 100,000 persons annually. In contrast, prosthetic joint infections occur in approximately 1% to 2% of primary hip and knee arthroplasties, representing a significant complication following arthroplasty procedures. Incidence trends show a notable decrease in pediatric cases following the introduction of the Haemophilus influenzae type b (Hib) vaccine in the 1980s and 1990s, which reduced Hib-related septic arthritis from contributing up to 34% of cases pre-vaccine to rare occurrences today, with overall pediatric rates now below 5 per 100,000. Adult rates have remained relatively stable over recent decades, though recent data indicate a rising incidence in adult populations driven by increasing comorbidities and injection drug use. Geographically, rates are higher in developing countries, reaching up to 20 cases per 100,000 annually, often linked to increased trauma and intravenous drug use.

At-risk populations

Septic arthritis exhibits varying incidence rates across different age groups, with neonates facing an elevated risk, with incidence rates of approximately 4 to 12 cases per 100,000 children, primarily due to infections from group B Streptococcus. In children aged 1 to 15 years, the incidence is approximately 5 cases per 100,000, often involving large lower limb joints. Among adults over 65 years, rates rise to 10 to 20 cases per 100,000, with a higher of gram-negative organisms contributing to the increased vulnerability in this demographic. Patients with represent a high-risk cluster, experiencing an incidence of 30 to 50 cases per 100,000, reflecting a 15-fold elevated compared to the general due to joint damage and immunosuppressive therapies. Intravenous drug users show an increased , with up to 11% of septic arthritis cases associated with injection drug use amid rising opioid epidemics. Individuals with face a 2- to 3-fold higher , exacerbated by impaired immune responses that heighten susceptibility to joint infections. In healthcare settings, postoperative prosthetic joint infections occur in 0.5% to 2% of cases following , posing a significant threat due to formation on implants. Dialysis patients, particularly those with end-stage renal disease, have an incidence of approximately 515 cases per 100,000 per year, representing over a 100-fold increase over the general population owing to frequent vascular access and immune compromise. Socioeconomic factors influence incidence, with higher rates observed in low-income areas due to barriers like delayed medical access and poorer living conditions. The condition is generally gender-neutral, though gonococcal septic arthritis disproportionately affects young females, who are more prone to disseminated infections. Indigenous populations, such as Australian Aboriginals, experience elevated rates of around 29 cases per 100,000, approximately six times higher than non-Indigenous groups, linked to disparities in healthcare access and environmental factors.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK538176/
  2. https://www.mayoclinic.org/diseases-conditions/bone-and-joint-infections/symptoms-causes/syc-20350755
  3. https://medlineplus.gov/ency/article/000430.htm
  4. https://emedicine.medscape.com/article/970365-clinical
  5. https://www.hopkinsmedicine.org/-/media/files/allchildrens/clinical-pathways/septic-arthritis-osteomyelitis-clinical-pathway-namtu-revised-4_24_25.pdf
  6. https://www.racgp.org.au/afp/2015/april/septic-arthritis-in-children
  7. https://caybdergi.com/articles/neonatal-septic-arthritis-a-case-report/cayd.galenos.2021.74436
  8. https://www.orthobullets.com/pediatrics/4032/hip-septic-arthritis--pediatric
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC2669005/
  10. https://jamanetwork.com/journals/jama/fullarticle/206421
  11. https://www.ncbi.nlm.nih.gov/books/NBK448131/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC8635410/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC3143964/
  14. https://ajronline.org/doi/10.2214/AJR.20.22773
  15. https://www.aafp.org/pubs/afp/issues/2021/1200/p589.html
  16. https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/infections-of-joints-and-bones/acute-infectious-arthritis
  17. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2811143
  18. https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2023.1193645/full
  19. https://emedicine.medscape.com/article/236299-overview
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC10214960/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC10895065/
  22. https://journals.asm.org/doi/10.1128/cmr.15.4.527-544.2002
  23. https://www.aafp.org/pubs/afp/issues/2011/0915/p653.html
  24. https://pubmed.ncbi.nlm.nih.gov/12364368/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC9901514/
  26. https://www.ncbi.nlm.nih.gov/books/NBK537114/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC6404712/
  28. https://emedicine.medscape.com/article/236299-workup
  29. https://rebelem.com/pediatric-septic-hip/
  30. https://emedicine.medscape.com/article/395381-overview
  31. https://www.acep.org/sonoguide/advanced/pediatric-hip
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC11694264/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC9436746/
  34. https://pubs.rsna.org/doi/abs/10.1148/radiographics.21.5.g01se191229
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC6611848/
  36. https://www.ncbi.nlm.nih.gov/books/NBK542164/
  37. https://www.ncbi.nlm.nih.gov/books/NBK546606/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC10929543/
  39. https://www.ncbi.nlm.nih.gov/books/NBK540151/
  40. https://pubmed.ncbi.nlm.nih.gov/35143028/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC6214374/
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC11195883/
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC7295646/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC11510638/
  45. https://pubmed.ncbi.nlm.nih.gov/7593582/
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC9533683/
  47. https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.22086
  48. https://www.ncbi.nlm.nih.gov/books/NBK531507/
  49. https://www.ncbi.nlm.nih.gov/books/NBK525999/
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC8555750/
  51. https://www.ncbi.nlm.nih.gov/books/NBK507704/
  52. https://emedicine.medscape.com/article/236299-treatment
  53. https://www.orthobullets.com/trauma/1058/septic-arthritis--adult
  54. https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/infections-of-joints-and-bones/prosthetic-joint-infectious-arthritis
  55. https://www.idsociety.org/practice-guideline/acute-bacterial-arthritis-in-pediatrics2/
  56. https://emedicine.medscape.com/article/970365-treatment
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC7654724/
  58. https://idmp.ucsf.edu/content/septic-arthritis
  59. https://emedicine.medscape.com/article/1268369-technique
  60. https://www.sciencedirect.com/science/article/pii/S2059775421000894
  61. https://orthopedicreviews.openmedicalpublishing.org/article/33754-the-eradication-rate-of-infection-in-septic-knee-arthritis-according-to-the-gachter-classification-a-systematic-review
  62. https://www.sciencedirect.com/science/article/pii/S2212628725002452
  63. https://www.orthobullets.com/recon/5004/prosthetic-joint-infection
  64. https://www.idsociety.org/practice-guideline/prosthetic-joint-infection/
  65. https://www.sicot-j.org/articles/sicotj/full_html/2017/01/sicotj150138/sicotj150138.html
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC11938927/
  67. https://www.sciencedirect.com/science/article/pii/S1658361220301670
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC4888402/
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC4098599/
  70. https://www.sciencedirect.com/science/article/pii/S2352344120300960
  71. https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-024-08147-w
  72. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182577
  73. https://www.mdpi.com/2076-3417/12/22/11679
  74. https://link.springer.com/article/10.1007/s00264-021-05013-5
  75. https://publications.aap.org/pediatricsinreview/article/32/11/470/32883/Arthritis-in-Children-and-Adolescents
  76. https://upload.orthobullets.com/journalclub/free_pdf/33273402_Current_Concepts_in_Pediatric_Septic_Arthritis.3.pdf
  77. https://www.mdpi.com/2077-0383/14/18/6403
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC11410400/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC6999997/
  80. https://www.tandfonline.com/doi/full/10.1080/13506129.2019.1693359
  81. https://journals.lww.com/pedorthopaedics/fulltext/1999/11000/reduction_in_osteomyelitis_and_septic_arthritis.3.aspx
  82. https://pmc.ncbi.nlm.nih.gov/articles/PMC12339463/
  83. https://www.sciencedirect.com/science/article/pii/S1875957220300243
  84. https://pmc.ncbi.nlm.nih.gov/articles/PMC9142763/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC5774603/
  86. https://www.infectiousdiseaseadvisor.com/news/iv-drug-use-associated-with-increased-mortality-in-septic-arthritis/
  87. https://academic.oup.com/ofid/article/3/suppl_1/1135/2637386
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC5496210/
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC2271655/
Add your contribution
Related Hubs
User Avatar
No comments yet.